Dr. Holly Pederson is the Director of the Medical Breast Program at the Cleveland Clinic and Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Her focus is on breast diagnostics, breast cancer risk assessment, and management of the high-risk patient.  She runs a Hereditary High-Risk Clinic for patients with identified genetic mutations predisposing to breast cancer and is actively involved in clinical research.

She is Board Certified in Internal Medicine, completed a clinical genetics fellowship at Cleveland Clinic in 2008 and City of Hope training in 2017. She serves on the Genomics High-Risk Focus Group at Cleveland Clinic as a member of the Cancer Genetics Program of the Case Comprehensive Cancer Center and on the NCCN Breast Cancer Risk Reduction Committee.